Literature DB >> 21738377

CD8+ Lymphomatoid Papulosis.

Ji Hyun Sim1, You Chan Kim.   

Abstract

Lymphomatoid papulosis (LyP) is defined as a histologically malignant, but clinically benign condition. It can appear as erythematous pink to purple papules or nodules. Immunophenotyping studies of the lymphomatoid papulosis lesions have shown a predominance of a CD4 expression and negativity for CD8. However, a positive CD8 expression has rarely been reported for LyP. Herein we report on a case of CD8 positive lymphomatoid papulosis in a 43-year-old man. The patient presented with erythematous, asymptomatic papules on the left axilla and thigh. Histopathologically, there was a wedge-shaped infiltrate composed of a mixture of various cell types, including lymphocytes, histiocytes, neutrophils and large atypical lymphoid cells. Immunophenotyping revealed the neoplastic cells were positive for CD3, CD8 and CD30 and they were negative for CD4, CD20 and CD56.

Entities:  

Keywords:  CD8+; Lymphomatoid papulosis

Year:  2011        PMID: 21738377      PMCID: PMC3119987          DOI: 10.5021/ad.2011.23.1.104

Source DB:  PubMed          Journal:  Ann Dermatol        ISSN: 1013-9087            Impact factor:   1.444


  7 in total

1.  Primary cutaneous CD8-positive epidermotropic cytotoxic T cell lymphomas. A distinct clinicopathological entity with an aggressive clinical behavior.

Authors:  E Berti; D Tomasini; M H Vermeer; C J Meijer; E Alessi; R Willemze
Journal:  Am J Pathol       Date:  1999-08       Impact factor: 4.307

2.  CD8+ lymphomatoid papulosis and its differential diagnosis.

Authors:  Cynthia M Magro; A Neil Crowson; Carl Morrison; Kambiz Merati; Pierluigi Porcu; E David Wright
Journal:  Am J Clin Pathol       Date:  2006-04       Impact factor: 2.493

3.  Increased risk of lymphoid and nonlymphoid malignancies in patients with lymphomatoid papulosis.

Authors:  H H Wang; T Myers; L J Lach; C C Hsieh; M E Kadin
Journal:  Cancer       Date:  1999-10-01       Impact factor: 6.860

Review 4.  WHO-EORTC classification for cutaneous lymphomas.

Authors:  Rein Willemze; Elaine S Jaffe; Günter Burg; Lorenzo Cerroni; Emilio Berti; Steven H Swerdlow; Elisabeth Ralfkiaer; Sergio Chimenti; José L Diaz-Perez; Lyn M Duncan; Florent Grange; Nancy Lee Harris; Werner Kempf; Helmut Kerl; Michael Kurrer; Robert Knobler; Nicola Pimpinelli; Christian Sander; Marco Santucci; Wolfram Sterry; Maarten H Vermeer; Janine Wechsler; Sean Whittaker; Chris J L M Meijer
Journal:  Blood       Date:  2005-02-03       Impact factor: 22.113

5.  Clinical, histopathologic, and immunophenotypic features of lymphomatoid papulosis with CD8 predominance in 14 pediatric patients.

Authors:  Aieska de Souza; Michael J Camilleri; David A Wada; David L Appert; Lawrence E Gibson; Rokea A el-Azhary
Journal:  J Am Acad Dermatol       Date:  2009-07-03       Impact factor: 11.527

6.  Lymphomatoid papulosis: a T-cell dyscrasia with a propensity to transform into malignant lymphoma.

Authors:  F Cabanillas; J Armitage; W C Pugh; D Weisenburger; M Duvic
Journal:  Ann Intern Med       Date:  1995-02-01       Impact factor: 25.391

7.  Lymphomatoid papulosis and associated lymphomas: a retrospective case series of 84 patients.

Authors:  J H Kunishige; H McDonald; G Alvarez; M Johnson; V Prieto; M Duvic
Journal:  Clin Exp Dermatol       Date:  2009-01-16       Impact factor: 3.470

  7 in total
  1 in total

1.  Lymphomatoid papulosis misdiagnosed as pityriasis lichenoides et varioliformis acuta: Two case reports and a literature review.

Authors:  Yan Zheng; Jinjing Jia; Qiong Tian; Xinyu Dong; Xin Wang; Zhaoxia Ying; Shengxiang Xiao; Wensheng Li
Journal:  Exp Ther Med       Date:  2014-10-07       Impact factor: 2.447

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.